Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Updates on the ERIC recommendations for immunoglobulin gene sequence analysis in CLL

Andreas Agathangelidis • 6 Oct 2022
ERIC 2022
Chronic Lymphocytic Leukemia Leukemia

Andreas Agathangelidis, PhD, Center for Research and Technology Hellas, Thermi, Greece, gives an update on the latest ERIC recommendations for immunoglobulin (IG) gene sequence analysis in chronic lymphocytic leukemia (CLL) which are focused on patients with nonproductive rearrangements and on how to interpret next-generation sequencing (NGS) results. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Andreas Agathangelidis

1:24
The interplay between genetic and environmental factors in MBL
Andreas Agathangelidis • 6 Oct 2022
0:36
The use of AI for analyzing genetic and molecular data in CLL
Andreas Agathangelidis • 6 Oct 2022
0:53
Clinical significance of Ig gene mutations in CLL
Andreas Agathangelidis • 6 Oct 2022
2:49
The past and present of immunoglobulin genes in CLL
Andreas Agathangelidis • 29 Sep 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals